MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas

FASEB Journal

Volumn 25, Issue 12, 2011, Pages 4138-4149

  Huang, Ruimin ^a   Cheung, Nai Kong V ^a   Vider, Jelena ^a   Cheung, Irene Y ^a   Gerald, William L ^a   Tickoo, Satish K ^a   Holland, Eric C ^a   Blasberg, Ronald G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Survival; Transcriptional regulation

Indexed keywords

BMI1 PROTEIN; MYC PROTEIN; PROTEIN MYCN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; E BOX ELEMENT; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NEUROBLASTOMA; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENES, MYC; HUMANS; INFANT; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; TRANSCRIPTIONAL ACTIVATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 82655173729     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-185033     Document Type: Article

References (37)

1. Maris, J. M., and Matthay, K. K. (1999) Molecular biology of neuroblastoma. J. Clin. Oncol. 17, 2264-2279 (Pubitemid 29318861)
2. Schwab, M., Westermann, F., Hero, B., and Berthold, F. (2003) Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol. 4, 472-480 (Pubitemid 37009955)
3. Cole, M. D., and McMahon, S. B. (1999) The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene 18, 2916-2924 (Pubitemid 29276532)
4. Dang, C. V., Resar, L. M., Emison, E., Kim, S., Li, Q., Prescott, J. E., Wonsey, D., and Zeller, K. (1999) Function of the c-Myc oncogenic transcription factor. Exp. Cell. Res. 253, 63-77
5. Slavc, I., Ellenbogen, R., Jung, W. H., Vawter, G. F., Kretschmar, C., Grier, H., and Korf, B. R. (1990) myc gene amplification and expression in primary human neuroblastoma. Cancer Res. 50, 1459-1463 (Pubitemid 20090455)
6. Gazitt, Y., He, Y. J., Chang, L., Koza, S., Fisk, D., and Graham- Pole, J. (1992) Expression of N-myc, c-myc, and MDR-1 proteins in newly established neuroblastoma cell lines: a study by immunofluorescence staining and flow cytometry. Cancer Res. 52, 2957-2965
7. Zhe, X., Chen, J., Liu, T., Zhang, L., Li, P., and Wang, D. (1999) The relationship between expressions of N-myc and c-myc oncogenes in neuroblastoma: an in situ hybridization and immunocytochemical study. Chin. Med. Sci. J. 14, 102-106
8. Castleberry, R. P. (1997) Neuroblastoma. Eur. J. Cancer 33, 1430-1437; discussion 1437-1438
9. Nowak, K., Kerl, K., Fehr, D., Kramps, C., Gessner, C., Killmer, K., Samans, B., Berwanger, B., Christiansen, H., and Lutz, W. (2006) BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas. Nucleic Acids Res. 34, 1745-1754
10. Ringrose, L., and Paro, R. (2004) Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu. Rev. Genet. 38, 413-443 (Pubitemid 40013734)
11. Valk-Lingbeek, M. E., Bruggeman, S. W., and van Lohuizen, M. (2004) Stem cells and cancer; the polycomb connection. Cell 118, 409-418 (Pubitemid 39485661)
12. Liu, S., Dontu, G., Mantle, I. D., Patel, S., Ahn, N. S., Jackson, K. W., Suri, P., and Wicha, M. S. (2006) Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 66, 6063-6071
13. Molofsky, A. V., He, S., Bydon, M., Morrison, S. J., and Pardal, R. (2005) Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev. 19, 1432-1437 (Pubitemid 41003009)
14. Park, I. K., Qian, D., Kiel, M., Becker, M. W., Pihalja, M., Weissman, I. L., Morrison, S. J., and Clarke, M. F. (2003) Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423, 302-305 (Pubitemid 40852701)
15. Haupt, Y., Alexander, W. S., Barri, G., Klinken, S. P., and Adams, J. M. (1991) Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice. Cell 65, 753-763 (Pubitemid 121001307)
16. Van Lohuizen, M., Verbeek, S., Scheijen, B., Wientjens, E., van der Gulden, H., and Berns, A. (1991) Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell 65, 737-752 (Pubitemid 121001306)
17. Sawa, M., Yamamoto, K., Yokozawa, T., Kiyoi, H., Hishida, A., Kajiguchi, T., Seto, M., Kohno, A., Kitamura, K., Itoh, Y., Asou, N., Hamajima, N., Emi, N., and Naoe, T. (2005) BMI-1 is highly expressed in M0-subtype acute myeloid leukemia. Int. J. Hematol. 82, 42-47 (Pubitemid 41512198)
18. Kim, J. H., Yoon, S. Y., Kim, C. N., Joo, J. H., Moon, S. K., Choe, I. S., Choe, Y. K., and Kim, J. W. (2004) The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett. 203, 217-224 (Pubitemid 38058689)
19. Kim, J. H., Yoon, S. Y., Jeong, S. H., Kim, S. Y., Moon, S. K., Joo, J. H., Lee, Y., Choe, I. S., and Kim, J. W. (2004) Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. Breast 13, 383-388 (Pubitemid 39549787)
20. Leung, C., Lingbeek, M., Shakhova, O., Liu, J., Tanger, E., Saremaslani, P., Van Lohuizen, M., and Marino, S. (2004) BMI1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 428, 337-341 (Pubitemid 38418806)
21. Jacobs, J. J., Kieboom, K., Marino, S., DePinho, R. A., and van Lohuizen, M. (1999) The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397, 164-168 (Pubitemid 29050921)
22. Dimri, G. P. (2005) What has senescence got to do with cancer? Cancer Cell 7, 505-512
23. Guo, W. J., Zeng, M. S., Yadav, A., Song, L. B., Guo, B. H., Band, V., and Dimri, G. P. (2007) Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells. Cancer Res. 67, 5083-5089 (Pubitemid 46997242)
24. Ochiai, H., Takenobu, H., Nakagawa, A., Yamaguchi, Y., Kimura, M., Ohira, M., Okimoto, Y., Fujimura, Y., Koseki, H., Kohno, Y., Nakagawara, A., and Kamijo, T. (2010) BMI1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bbeta and TSLC1 in neuroblastoma. Oncogene 29, 2681-2690
25. Alaminos, M., Gerald, W. L., and Cheung, N. K. (2005) Prognostic value of MYCN and ID2 overexpression in neuroblastoma. Pediatr. Blood Cancer 45, 909-915 (Pubitemid 41552158)
26. Alaminos, M., Mora, J., Cheung, N. K., Smith, A., Qin, J., Chen, L., and Gerald, W. L. (2003) Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma. Cancer Res. 63, 4538-4546 (Pubitemid 36951027)
27. Rizo, A., Dontje, B., Vellenga, E., de Haan, G., and Schuringa, J. J. (2008) Long-term maintenance of human hematopoietic stem/progenitor cells by expression of BMI1. Blood 111, 2621-2630
28. Tomayko, M. M., and Reynolds, C. P. (1989) Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother. Pharmacol. 24, 148-154 (Pubitemid 19163397)
29. Cui, H., Hu, B., Li, T., Ma, J., Alam, G., Gunning, W. T., and Ding, H. F. (2007) Bmi-1 is essential for the tumorigenicity of neuroblastoma cells. Am. J. Pathol. 170, 1370-1378 (Pubitemid 47339343)
30. Cui, H., Ma, J., Ding, J., Li, T., Alam, G., and Ding, H. F. (2006) Bmi-1 regulates the differentiation and clonogenic self-renewal of I-type neuroblastoma cells in a concentration-dependent manner. J. Biol. Chem. 281, 34696-34704 (Pubitemid 46036675)
31. Malynn, B. A., de Alboran, I. M., O'Hagan, R. C., Bronson, R., Davidson, L., DePinho, R. A., and Alt, F. W. (2000) N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev. 14, 1390-1399 (Pubitemid 30397082)
32. Iyengar, R. V., Pawlik, C. A., Krull, E. J., Phelps, D. A., Burger, R. A., Harris, L. C., Potter, P. M., and Danks, M. K. (2001) Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expression. Cancer Res. 61, 3045-3052 (Pubitemid 32691953)
33. Maris, J. M. (2005) The biologic basis for neuroblastoma heterogeneity and risk stratification. Curr. Opin. Pediatr. 17, 7-13
34. Mora, J., Cheung, N. K., and Gerald, W. L. (2001) Genetic heterogeneity and clonal evolution in neuroblastoma. Br. J. Cancer 85, 182-189 (Pubitemid 32695737)
35. Ross, R. A., and Spengler, B. A. (2004) The conundrum posed by cellular heterogeneity in analysis of human neuroblastoma. J. Natl. Cancer Inst. 96, 1192-1193 (Pubitemid 39232700)
36. Guney, I., Wu, S., and Sedivy, J. M. (2006) Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16(INK4a). Proc. Natl. Acad. Sci. U. S. A. 103, 3645-3650 (Pubitemid 43376609)
37. Giannini, G., Cerignoli, F., Mellone, M., Massimi, I., Ambrosi, C., Rinaldi, C., Dominici, C., Frati, L., Screpanti, I., and Gulino, A. (2005) High mobility group A1 is a molecular target for MYCN in human neuroblastoma. Cancer Res. 65, 8308-8316 (Pubitemid 41330595)